Literature DB >> 1606789

Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis.

G R Bailie1, G Eisele, R A Venezia, D Yocum, A Hollister.   

Abstract

The pharmacokinetics of vancomycin were studied in continuous ambulatory peritoneal dialysis patients with peritonitis. Six patients received an intraperitoneal loading dose of 15 mg/kg and 4 received an intraperitoneal dose of 25 mg/L. The ability of 2 methods to predict serum concentrations during the loading dose exchange was determined. The mean serum concentration after the exchange was 17.8 +/- 2.2 mg/L in patients receiving the loading dose. The mean dialysis clearance in all patients was 0.94 +/- 0.34 L/h. 66.6 +/- 13.4% of a dose was absorbed into the circulation in 4 h. The volume of distribution was 0.61 +/- 0.46 L/kg, and the half-life for equilibration of vancomycin into the circulation from dialysate was 2.76 +/- 0.94 h. Two methods of predicting serum vancomycin concentrations were tested, with 1 method predicting values significantly different from measured concentrations while the other did not. Serum vancomycin concentrations can be accurately predicted during a loading dose exchange.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1606789     DOI: 10.2165/00003088-199222040-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  12 in total

1.  Red-neck syndrome associated with intraperitoneal vancomycin.

Authors:  G R Bailie; S F Kowalsky; G Eisele
Journal:  Clin Pharm       Date:  1990-09

Review 2.  Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetic considerations.

Authors:  E Keller; P Reetze; P Schollmeyer
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

3.  Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.

Authors:  D Neal; G R Bailie
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

4.  Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  R D Blevins; C E Halstenson; N G Salem; G R Matzke
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

5.  The epidemiology of peritonitis caused by coagulase-negative staphylococci in continuous ambulatory peritoneal dialysis.

Authors:  H A Ludlam; W C Noble; R R Marples; R Bayston; I Phillips
Journal:  J Med Microbiol       Date:  1989-11       Impact factor: 2.472

6.  Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?

Authors:  G R Bailie; R Morton; L Ganguli; M Keaney; S Waldek
Journal:  Nephron       Date:  1987       Impact factor: 2.847

7.  The 1987 USA National CAPD Registry report.

Authors:  A S Lindblad; J W Novak; K D Nolph; D M Stablein; S J Cutler
Journal:  ASAIO Trans       Date:  1988 Apr-Jun

8.  Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport.

Authors:  M C Rogge; C A Johnson; S W Zimmerman; P G Welling
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

9.  Vancomycin kinetics during continuous ambulatory peritoneal dialysis.

Authors:  C M Bunke; G R Aronoff; M E Brier; R S Sloan; F C Luft
Journal:  Clin Pharmacol Ther       Date:  1983-11       Impact factor: 6.875

10.  Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis.

Authors:  G D Morse; D F Farolino; M A Apicella; J J Walshe
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

View more
  2 in total

Review 1.  Clinical pharmacokinetics during continuous ambulatory peritoneal dialysis.

Authors:  C A Taylor; E Abdel-Rahman; S W Zimmerman; C A Johnson
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

2.  Vancomycin: the tale of the vanquisher and the pyrrhic victory.

Authors:  An S De Vriese; Stefaan J Vandecasteele
Journal:  Perit Dial Int       Date:  2014 Mar-Apr       Impact factor: 1.756

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.